← Eichor
Study identifier: NCT06426953 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Predictive Effect of TGF-β and INS-PI3K-AKT Related Proteins for POD in Diabetes Patients

Condition: Diabetes · Postoperative Delirium  ·  Sponsor: Xie Kangjie

PhaseN/A
Planned participants180
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

To investigate the relationship between POD, TGF-β and INS-PI3K-AKT signaling pathway related proteins (ADNP, MAP6, PGC-1α) in diabetic patients

This description comes directly from the study's public registry record.

Talk to the study team

Kangjie Xie, MD  ·  8613516721870  ·  xiekj@zjcc.org.cn

Always discuss trial participation with your own doctor first.

Locations (2)

The People's hospital of QiannanDuyun, Guizhou, ChinaNot Yet Recruiting
Zhejiang Cancer HospitalHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06426953